Listen to this Post
Introduction
The idea of bringing extinct animals back to life once belonged to science fiction. Today, it is becoming a serious scientific pursuit. Biotechnology company Colossal has announced that the bluebuck, an antelope species hunted to extinction more than 200 years ago, is now one of its top de-extinction projects. If successful, the animal could be born again as early as 2028.
This bold announcement places the bluebuck alongside the woolly mammoth and dire wolf in a growing list of species Colossal hopes to restore through advanced genetic engineering. While supporters see hope for biodiversity and conservation, critics warn that reviving extinct animals may create more problems than solutions.
Bluebuck Could Return After Two Centuries
The bluebuck was once native to what is now South Africa. It was known for its rare silvery-blue coat, which gave the species its memorable name. Overhunting and habitat loss led to its disappearance in the late 18th or early 19th century, making it one of the first large African mammals driven to extinction in modern history.
Colossal says the bluebuck is now the sixth species added to its de-extinction portfolio. According to CEO Ben Lamm, scientists have already recovered usable bluebuck DNA, mapped its genome, and compared it with the species’ closest living relatives.
The company claims it is now entering the most technically challenging phase: genomic editing. This step involves rewriting the DNA of a living relative so it closely matches the extinct species. If all goes according to plan, the first revived bluebuck could be born around 2028 through a surrogate pregnancy lasting roughly nine months.
Rewilding Is the Long-Term Goal
Colossal says its mission goes beyond simply creating animals in laboratories. The company wants revived species to eventually live in protected natural habitats where they can contribute to ecosystems.
For the bluebuck, this could mean carefully managed rewilding programs in South Africa. Colossal says local conservation groups support the concept. The idea would be to place future animals in environments resembling their original habitat, helping restore ecological balance while protecting them from modern threats.
Lamm also made clear that Colossal is not trying to build a zoo full of prehistoric or extinct animals. Instead, he says any public viewing opportunities would depend on governments, indigenous communities, and local conservation authorities.
Mammoth Project Still Moving Forward
While the bluebuck announcement is generating attention, Colossal’s most famous effort remains the woolly mammoth project. The company says that project is also on schedule, with hopes for a first birth in 2028.
Scientists are reportedly in the final stages of gene editing and preparing for embryo transfer into elephants, which would serve as surrogates. If successful, it would mark one of the most ambitious biotechnology experiments in modern history.
Critics Continue to Challenge De-Extinction Claims
Despite the excitement, many experts remain skeptical. Some researchers previously argued that Colossal’s so-called dire wolves are not true dire wolves at all. Instead, they describe them as genetically modified grey wolves designed to resemble extinct animals.
That criticism raises a deeper question: when does an engineered animal become the species it imitates? If the DNA is partly modern and partly reconstructed, some scientists argue it may be better described as a proxy species rather than a genuine resurrection.
Others worry about ecological consequences. Reintroducing extinct animals into modern ecosystems could disrupt food chains, spread disease, or create competition with species that adapted in their absence.
Science, Ethics, and the Future of Conservation
The bluebuck project highlights how quickly biotechnology is advancing. Just a decade ago, editing the genome of extinct species at this scale seemed nearly impossible. Today, it is being discussed with timelines and delivery targets.
Still, scientific capability does not automatically settle ethical questions. Should humans revive species we once destroyed? Would funding be better spent protecting endangered animals that are still alive today? Could de-extinction distract from urgent habitat preservation efforts?
These questions will likely become louder as Colossal moves closer to actual births rather than announcements.
What Undercode Say:
Colossal’s bluebuck project is not just about one extinct antelope. It is about proving a repeatable business and scientific model. If the company successfully revives the bluebuck, it gains credibility, investor confidence, and a stronger platform for larger projects like mammoths or thylacines.
The selection of the bluebuck is strategic. Unlike predators, antelope species may be easier to justify ecologically because herbivores are often less controversial and easier to place in managed reserves. That reduces public fear while increasing the chances of political support.
South Africa also provides a compelling conservation narrative. A species hunted to extinction by humans returning through human technology creates a symbolic full-circle story. That kind of narrative matters in media, fundraising, and public acceptance.
However, the technical challenge remains enormous. Ancient DNA is fragmented and incomplete. Scientists must fill missing genetic gaps using living relatives, which means the final animal may only approximate the original bluebuck. That may still be valuable scientifically, but it changes the meaning of the word “revived.”
Another key issue is economics. De-extinction requires massive funding, highly specialized talent, and long timelines. If no profitable model exists beyond publicity and patents, sustaining multiple species programs may become difficult.
Yet Colossal may be betting that technologies developed during these efforts, such as fertility science, gene editing tools, and biodiversity applications, will become the true commercial assets. In that case, extinct animals are both mission and marketing vehicle.
There is also a geopolitical dimension. Countries with extinct native species may one day partner with biotech firms to restore symbolic wildlife. That could create a new global industry linking conservation, tourism, and national identity.
Still, conservationists are right to be cautious. Protecting rhinos, elephants, and existing antelope species may provide faster ecological returns than recreating one that vanished centuries ago. De-extinction should complement conservation, not replace it.
If the bluebuck succeeds, public opinion on biotechnology could shift dramatically. People who fear gene editing may begin seeing it as restoration rather than manipulation. That cultural shift alone could have major ripple effects beyond wildlife science.
In the end, the bluebuck may become more than an animal. It could become a test case for whether humanity uses technology to repair old damage or simply chase headlines.
Fact Checker Results
✅ Colossal has publicly promoted multiple de-extinction projects including mammoths and dire wolves.
✅ Bluebuck was a real extinct South African antelope species lost more than two centuries ago.
❌ It is not yet confirmed that any revived bluebuck exists today; the project remains in development stages.
Prediction
🔮 If Colossal achieves even one successful bluebuck birth, global investment in de-extinction startups will surge.
🔮 Governments may begin exploring restoration deals for culturally important extinct species.
🔮 Debate over ethics and “what counts as real resurrection” will intensify worldwide.
🕵️📝Let’s dive deep and fact‑check.
References:
Reported By: axioscom_1777551094
Extra Source Hub (Possible Sources for article):
https://www.stackexchange.com
Wikipedia
OpenAi & Undercode AI
Image Source:
Unsplash
Undercode AI DI v2
Bing
🔐JOIN OUR CYBER WORLD [ CVE News • HackMonitor • UndercodeNews ]
📢 Follow UndercodeNews & Stay Tuned:
𝕏 formerly Twitter 🐦 | @ Threads | 🔗 Linkedin | 🦋BlueSky | 🐘Mastodon
